Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The U.S.Food and Drug Administration has approved Rituxan in combination with glucocorticoids to treat patients withWegener’s granulomatosis and microscopic polyangiitis.
The U.S.Food and Drug Administration has approved subcutaneous Gammagard Liquid 10% for patients with primary immunodeficiency.
Researchers at the University ofEdinburgh have found a direct link between the workings of the immune system and cholesterol levels.
The U.S. Food and Drug Administration has approved Kedrion Biopharma’s Gammaked for the U.S.market.
The Department of Health and Human Services issued a final regulation ensuring that large health insurance premium increases will be reviewed and accessible to consumers.
Nanopatch, a needle-free vaccine delivery system, is a step closer to reality after a consortium of investors donated to its development.
The National Institute on Aging and the Alzheimer’s Association have revised versions of an initial set of guidelines for diagnosing Alzheimer’s disease.
The average monthly premium for Medicare Part D prescription drug coverage will decline in 2012, according to the U.S. Department of Health and Human Services.
A new study is enrolling women who have had exposure to a meningitis vaccine during the first trimester of pregnancy to determine the vaccine’s safety.
Menactra, a vaccine for the prevention of invasive meningococcal disease for children ages 9 months and older, has been approved by the U.S. Food and Drug Administration.
Engineers at MIT have designed anew type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.